Physician profile

Eric A Hong

Cardiovascular Disease · La Jolla, CA

NPI 1013162452

$15,970.70

in general payments reported to CMS, 2019-2025

53 companies · $2,417 in 2025

The $2,417 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$8,792.74

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Novartis Pharmaceuticals Corporation $1,462.70 2019-2025
Medtronic, INC. $973.99 2021-2025 Linq II, Aurora Ev-Icd Mri Surescan, Mycarelink
Amgen INC. $954.56 2019-2025 Repatha, Repatha
Cvrx, INC. $932.86 2022-2025 Barostim Neo System
Abbott Laboratories $881.40 2019-2025 Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Amulet
Pfizer INC. $865.66 2019-2025
Merck Sharp & Dohme LLC $853.44 2021-2025 Verquvo
Boston Scientific Corporation $835.79 2019-2025 Watchman Access System, Watchman Flx, Wavewriter Alpha Prime 16
Janssen Pharmaceuticals, INC $709.74 2019-2024 Xarelto
Bardy Diagnostics, INC. $685.60 2020-2022
Esperion Therapeutics, INC. $657.82 2021-2025 Nexletol, Nexlizet
Astrazeneca Pharmaceuticals LP $628.51 2019-2025 Farxiga, Andexxa, Brilinta
E.R. Squibb & Sons, L.L.C. $469.80 2019-2025 Camzyos, Eliquis
Sanofi-Aventis U.S. LLC $462.52 2019-2022
Regeneron Healthcare Solutions, INC. $347.34 2019-2025 Evkeeza
Show all 53 companies
CompanyGeneral paymentsYearsTop products
Actelion Pharmaceuticals US, INC. $313.32 2019-2023 Uptravi, Opsumit
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $307.84 2019-2024 Lifevest
Novo Nordisk INC $307.34 2021-2024 Rybelsus, Ozempic
Irhythm Technologies, INC. $305.72 2019-2024 Zio Xt Patch, Zio Monitor
Alnylam Pharmaceuticals INC. $258.37 2020-2025 Amvuttra
Abiomed $243.94 2023-2025 Impella
Medtronic Vascular, INC. $226.09 2019-2020
Heartflow, INC. $222.18 2019-2025
B. Braun Interventional Systems INC. $185.39 2023 Ono Retrieval Device
Amarin Pharma, INC. $168.26 2019-2022
Kiniksa Pharmaceuticals, LTD. $163.28 2021-2023 Arcalyst
Boehringer Ingelheim Pharmaceuticals, INC. $160.08 2019-2025 Jardiance
Kestra Medical Technology Services, INC. $141.49 2024-2025 Assure Wcd
Biosense Webster, INC. $135.05 2022
Janssen Biotech, INC. $126.65 2025 Tremfya
Tactile Systems Technology INC $122.42 2019-2025 Flexitouch Plus, Entre Plus, Nimbl
Kowa Pharmaceuticals America, INC. $86.27 2019-2021
Chiesi USA, INC. $84.53 2019-2024 Kengreal
Baxter Healthcare $74.61 2023-2025 Hillrom - Cardiac Ambulatory Monitor
Lexicon Pharmaceuticals, INC. $72.33 2023-2024 Inpefa
Kiniksa Pharmaceuticals International, Plc $64.82 2024 Arcalyst
Bayer Healthcare Pharmaceuticals INC. $63.75 2021-2025
Glaxosmithkline, LLC. $54.03 2019-2025 Shingrix
Scpharmaceuticals INC. $38.13 2023
Lundbeck LLC $37.30 2019
Lantheus Medical Imaging, INC. $35.23 2019-2020
Daiichi Sankyo INC. $28.84 2023 Injectafer
Cleerly, INC. $27.13 2025 Cleerly Ischemia, Cleerly Labs
Impulse Dynamics (USA) INC. $24.58 2022
Biotronik INC. $24.45 2022
Philips North America LLC $23.65 2024 (Ck4) Mcot
Otsuka America Pharmaceutical, INC. $22.67 2019
Portola Pharmaceuticals, LLC $21.54 2019
Atricure, INC. $20.95 2022
Inspire Medical Systems, INC. $18.23 2025 Inspire
Celgene Corporation $18.17 2023 Camzyos
Gilead Sciences, INC. $15.81 2019
Coala Life INC $4.53 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eric A Hong

$15,970.70

in general payments reported 2019-2025

Years
2019-2025
Top company
Novartis Pharmaceuticals Corporation
Context
The $2,417 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/182116/eric-a-hong

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.